Trial intelligence / Profile preview

Tranexamic acid followed by aspirin for aneurysmal subarachnoid hemorrhage

NL-OMON27006Not yet recruiting

Sponsor
Germans / Coert Research Group
Start
Dec 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in subarachnoid hemorrhage (SAH) comparing Placebo control with Tranexamic acid followed by aspirin (2 arms). Primary endpoint: Modified Rankin Scale. Planned start Dec 2009; status: not yet recruiting.

02

Drugs

tranexamic acidaspirin
03

Conditions

subarachnoid hemorrhage (SAH)

Beyond the preview

Go deeper on NL-OMON27006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON27006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call